The DWC is accepting public comments on rules that expedite medical benefits and the dispute resolution process until November 24th.
The DWC is accepting public comments on rules that expedite medical benefits and the dispute resolution process until November 24th.
The Medical Fee Guide Committee also discussed PPO practices, psychiatric IMEs, and more.
Findings from a gabapentin/pregabalin audit are expected in early 2026, the DWC addressed billing discrepancies, and more.
Stakeholders provided feedback on the DWC’s proposed rules.
Written comments will be accepted via email until November 10th.
Fee schedule rates haven’t changed since 2009, and the low rates have discouraged provider participation.
While injured workers can choose any Level I or II provider from the DWC’s panel, employers and insurers may still share preferred or in-house lists.
Interested stakeholders must submit written comments by October 28th.
A recap of conference highlights and key presentations.
Stakeholders discussed inefficiencies in claim procedures, and regulators will continue to review feedback prior to finalizing recommendations.
BWC resubmits outpatient medication rules with unchanged compound provisions, sets February 2026 start date, and reopens public comments.
A small group of prescribers and out-of-network pharmacies are driving utilization of costly drugs with affordable alternatives.
Advocacy efforts by Healthesystems helped create a prior authorization for 300mg ibuprofen, as other cost-effective doses are readily available.
Three listening sessions will give stakeholders the chance to comment on how to implement major workers’ comp reforms.
The EOHHS hopes to understand how current rates affect workers’ comp coverage, access to care, quality of care, and injured worker experience.
